Last quarter (Q4 2023), Ionis Pharmaceuticals's total revenue was $324.50M, an increase of 113.65% from the same quarter last year. In Q4, Ionis Pharmaceuticals's net income was $-1.35B. See Ionis Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 709.75M	$ 787.65M	$ 587.37M	$ 810.46M	$ 729.26M	$ 1.12B
Cost of Revenue	$ 206.95M	$ 9.13M	$ 14.12M	$ -10.84M	$ 11.95M	$ 4.38M
Gross Profit	$ 810.63M	$ 778.51M	$ 573.25M	$ 156.16M	$ 717.32M	$ 1.12B
Operating Expense	$ 232.62M	$ 232.62M	$ 983.44M	$ 186.35M	$ 867.28M	$ 752.29M
Operating Income	$ 106.12M	$ -353.73M	$ -410.19M	$ -30.19M	$ -149.96M	$ 365.93M
Net Non Operating Interest Income Expense	$ 26.76M	$ -12.66M	$ -8.12M	$ 695.00K	$ -9.40M	$ -48.77M
Other Income Expense	$ -61.80M	$ -101.22M	$ 160.33M	$ -343.00K	$ 24.84M	$ 29.65M
Pretax Income	$ -318.45M	$ -333.96M	$ -257.99M	$ -29.15M	$ -134.55M	$ 346.77M
Tax Provision	$ 32.32M	$ 32.32M	$ 11.74M	$ -551.00K	$ 345.19M	$ 43.51M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -1.25B	$ -366.29M	$ -269.72M	$ -28.60M	$ -444.26M	$ 296.56M
Basic EPS	$ -2.56	$ -2.56	$ -1.90	$ -0.20	$ -3.23	$ 2.12
Diluted EPS	$ -2.56	$ -2.56	$ -1.90	$ -0.20	$ -3.23	$ 2.08
Basic Average Shares	$ 572.76M	$ 143.19M	$ 141.85M	$ 141.02M	$ 139.61M	$ 140.00M
Diluted Average Shares	$ 572.76M	$ 143.19M	$ 141.85M	$ 141.02M	$ 139.61M	$ 142.87M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 439.56M	$ 241.75M	$ 997.56M	$ 175.50M	$ 879.22M	$ 756.67M
Net Income From Continuing And Discontinued Operation	$ -366.29M	$ -366.29M	$ -269.72M	$ -28.60M	$ -444.26M	$ 294.15M
Normalized Income	$ -174.45M	$ -263.67M	$ -370.28M	-	$ -462.51M	$ 267.63M
Interest Expense	-	-	$ 8.12M	-	$ 6.20M	$ 48.77M
EBIT	$ -305.79M	$ -321.31M	$ -249.86M	$ -19.80M	$ -128.35M	$ 395.54M
EBITDA	$ -305.85M	$ -321.36M	$ -227.76M	$ 22.50M	$ -111.19M	$ 411.53M

Currency in USD

Ionis Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing